Titan Medical Inc (TMDIF)

[was CUIN2]

IMO the recent death knell in TRXC's PPS is more directly tied to the financing/offering price of the shares "after" the reverse split. Reverse splits in and of themselves don't change Market Cap, but rather reduce number of outstanding shares, thus increasing each shares value. It's what a company does or does not do after a reverse split that further impacts PPS.

In Transenterix's case, they cleverly thought to attract more investors we'll discount the Reverse Split share price of a share from $10 all the way down to $4 (60% discount). They were trying to tell the market "Look at what a deal this is, 60% discount" but the market said "this company has been overvalued, even $4 is too high" and now it's really trading at about $.47 PPS pre-reverse split. Obviously recent news has also impacted PPS also, but investors invested prior to the reverse spilt have to get to $10 PPS to break even or be where they were prior to R/S.

Lesson: just because a strategy is feasible, doesn't mean it is advisable.